Outcome of Allogeneic Stem Cell Transplantation for Patients Transformed to Myelodysplastic Syndrome or Leukemia from Severe Aplastic Anemia: A Report from the MDS Subcommittee of the Chronic Malignancies Working Party and the Severe Aplastic Anemia Working Party of the European Group for Blood and Marrow Transplantation

Author(s):
Hussein, A.A.; Halkes, C.M.; Socie, G.; Tichelli, A.; Borne, P.A. von dem; Schaap, M.N.P.M.; Foa, R.; Ganser, A.; Dufour, C.; Bacigalupo, A.; Locasciulli, A.; Aljurf, M.; Peters, C.; Robin, M.; Biezen, A.A. van; Volin, L.; Witte, T. de; Marsh, J.; Passweg, J.R.; Kroger, N.; Severe Aplastic Anemia Chronic
Published
2014
Publication type
Article / Letter to editor
Hematopoietic stem cell transplantationSevere aplastic anemiaMyelodysplastic syndromeAcute myelogenous leukemia
Date issued
2014-09-30
Language
English
Is part of
Biology of Blood and Marrow Transplantation (2014), Vol. 20, no. 9, p. 1448-1450
hdl
1887/104427
doi
10.1016/j.bbmt.2014.05.028